Aclarubicin in the treatment of relapsed or resistant acute myelogenous leukaemia: a phase II trial.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/4CC6F3C2.svg?ark=w1%2F20260515%2F4CC6F3C2)](https://nobleid.org/work/w1/20260515/4CC6F3C2)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors